Please login to the form below

Not currently logged in
Email:
Password:

OctreoPharm

This page shows the latest OctreoPharm news and features for those working in and with pharma, biotech and healthcare.

Ipsen searches for new CEO after splitting top roles

Ipsen searches for new CEO after splitting top roles

The company has also been building up its neuroendocrine tumours (NET) franchise, recently launching Somatuline (lanreotide) in the US and Europe and acquiring OctreoPharm Sciences, which has a NET therapy in

Latest news

  • Ipsen acquires OctreoPharm to boost its oncology presence Ipsen acquires OctreoPharm to boost its oncology presence

    OctreoPharm focuses on the development of innovative radioactive labelled compounds for molecular imaging and diagnostics and therapeutic applications. . ... OctreoPharm has a unique expertise in antagonist peptides for the diagnosis and treatment of

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics